TUSTIN, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient ...
Avid reported quarterly fiscal results on Tuesday. The company reported sales of $43 million beating analyst estimates of $42.14 million. Every week, our Whisper Index uncovers five overlooked stocks ...
-- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditure Associated with Three-Year Expansion Program Completed -- -- FY 2025 Revenue Guidance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results